2019 annual financial data
CytomX Therapeutics 2019 Net margin
CytomX Therapeutics 2019 net margin with verified reported values.
Direct answer
Net margin was -177.84%.
Operating income was -110,895,000 USD and net income was -102,238,000 USD.
Operating cash flow was -140,480,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 57,489,000 USD
- Operating income
- -110,895,000 USD
- Net income
- -102,238,000 USD
- Operating cash flow
- -140,480,000 USD